SEARCH
Alembic Pharma Receives U.S. FDA Approval For Breast Cancer Injection
NDTV Profit
2022-12-27
Views
5
Description
Share / Embed
Download This Video
Report
#AlembicPharma receives U.S. #FDA's approval for Fulvestrant Injection, which is used in treatment of breast cancer.
CFO Rajkumar Kumar Baheti shares what it means for the company. #BQLive
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x8go3xg" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
12:23
Alembic Pharma: New Product Launches On The Horizon? | NDTV Profit
14:50
Nifty Pharma & FMCG Continue To Outperform | Trade Setup: March 24 | BQ Prime
18:17
Stocks In Focus: UltraTech, ONGC, Techno Electric, Aurobindo Pharma & More | BQ Prime
17:35
Stocks In Focus: Auto Stocks , HDFC AMC, Coal India, Aurobindo Pharma, & More | BQ Prime
02:31
BQ Exclusive: Sun Pharma Maybe Third Time Lucky After Latest U.S. FDA Inspection
14:13
Stocks In Focus | Zomato, Sula, BHEL, RVNL, Ajanta Pharma & More | BQ Prime
15:24
Stocks In Focus: Pharma, Metals, HDFC & More | BQ Prime
11:14
Pharma & Defensives Are Pockets Of Long Trade | Trade Setup: March 27 | BQ Prime
10:02
APIs Are Now Costlier By 12-25%: Impact On Pharma Companies| BQ Prime
25:31
BQ Conversations | Quadria Capital's Amit Varma On Pharma & Healthcare Space
12:57
Stocks In Focus | JFS, Torrent Pharma, Polymed, Hindalco & More | BQ Prime
15:15
Stocks In Focus: IT Sector, Gland Pharma, Thomas Cook, Ramco Cements & More | BQ Prime